|
NL128591C
(me)
*
|
1965-07-02 |
|
|
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4230705A
(en)
*
|
1976-09-22 |
1980-10-28 |
American Cyanamid Company |
6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
|
|
US4242515A
(en)
|
1979-03-28 |
1980-12-30 |
American Cyanamid Company |
Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
|
|
US4244953A
(en)
|
1979-10-24 |
1981-01-13 |
American Cyanamid Company |
Substituted 6-phenyl-5,6,7,8-tetrahydro-1,2,4-triazolo-[4,3-a]pyridines
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US4812565A
(en)
|
1982-09-30 |
1989-03-14 |
A. H. Robins Company, Incorporated |
Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
|
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
|
US4654343A
(en)
*
|
1985-10-31 |
1987-03-31 |
American Cyanamid Company |
N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US4746655A
(en)
|
1987-06-10 |
1988-05-24 |
A. H. Robins Company, Incorporated |
Fused aromatic-spiropiperidine oxazepinones(and thiones)
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4902514A
(en)
|
1988-07-21 |
1990-02-20 |
Alza Corporation |
Dosage form for administering nilvadipine for treating cardiovascular symptoms
|
|
DE4010488A1
(de)
|
1990-03-31 |
1991-10-02 |
Hoechst Ag |
Benzoxazinderivate, verfahren zu ihrer herstellung und ihre verwendung zum behandeln oder zur prophylaxe von krankheiten
|
|
CA2044564A1
(en)
*
|
1990-06-28 |
1991-12-29 |
Quirico Branca |
Amino acid derivatives
|
|
CN1060467A
(zh)
|
1990-09-25 |
1992-04-22 |
武田药品工业株式会社 |
1，3-苯并嗪衍生物、其生产方法和用途
|
|
JPH04209692A
(ja)
|
1990-12-03 |
1992-07-31 |
Asahi Glass Co Ltd |
フォトクロミック材料
|
|
ATE152102T1
(de)
|
1991-05-10 |
1997-05-15 |
Takeda Chemical Industries Ltd |
Pyridinderivate, deren herstellung und anwendung
|
|
ES2190428T3
(es)
|
1991-06-28 |
2003-08-01 |
Smithkline Beecham Corp |
Antagonistas biciclicos de fibrinogeno.
|
|
US5939412A
(en)
|
1992-06-26 |
1999-08-17 |
Smithkline Beecham Corporation |
Bicyclic fibrinogen antagonists
|
|
US5674863A
(en)
|
1991-10-18 |
1997-10-07 |
Genentech, Inc. |
Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
|
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
|
US5272158A
(en)
|
1991-10-29 |
1993-12-21 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
JPH06107647A
(ja)
|
1992-08-12 |
1994-04-19 |
Takeda Chem Ind Ltd |
１，３−ベンゾオキサジン誘導体の製造法
|
|
US6011150A
(en)
|
1992-11-13 |
2000-01-04 |
Tanabe Seiyaku Co., Ltd. |
Azetidinone compound and process for preparation thereof
|
|
US5442055A
(en)
|
1992-11-13 |
1995-08-15 |
Tanabe Seiyaku Co., Ltd. |
Azetidinone compound and process for preparation thereof
|
|
GB9225860D0
(en)
|
1992-12-11 |
1993-02-03 |
Smithkline Beecham Plc |
Novel treatment
|
|
GB9226302D0
(en)
|
1992-12-17 |
1993-02-10 |
Smithkline Beecham Plc |
Pharmaceuticals
|
|
US5550229A
(en)
|
1993-06-23 |
1996-08-27 |
Tanabe Seiyaku Co., Ltd. |
Alkylation process for preparing azetidinone compound and starting compound therefor
|
|
DE19526173A1
(de)
|
1995-07-18 |
1997-01-30 |
Hoechst Ag |
Polyfullerenaddukte, Verfahren zu ihrer regioselektiven Herstellung und deren Verwendung
|
|
JPH09157262A
(ja)
|
1995-12-08 |
1997-06-17 |
Tanabe Seiyaku Co Ltd |
アゼチジノン誘導体及びその合成中間体の製法
|
|
GB9619492D0
(en)
|
1996-09-18 |
1996-10-30 |
Smithkline Beecham Plc |
Novel treatment
|
|
WO1998047885A1
(en)
|
1997-04-18 |
1998-10-29 |
Smithkline Beecham Plc |
A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
|
|
JP3964053B2
(ja)
|
1997-07-10 |
2007-08-22 |
三井化学株式会社 |
遷移金属化合物からなるオレフィン重合用触媒ならびに重合方法
|
|
TR200000624T2
(tr)
|
1997-09-08 |
2000-11-21 |
Unilever N.V. |
Bir enzimin etkinliğinin arttırılması ile ilgili bir yöntem.
|
|
WO1999037644A1
(en)
*
|
1998-01-21 |
1999-07-29 |
Merck Sharp & Dohme Limited |
Triazolo-pyridazine derivatives as ligands for gaba receptors
|
|
WO1999041246A1
(en)
|
1998-02-11 |
1999-08-19 |
Du Pont Pharmaceuticals Company |
Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
|
|
IL137720A0
(en)
|
1998-02-18 |
2001-10-31 |
Neurosearch As |
Compounds and their use as positive ampa receptor modulators
|
|
CA2334836A1
(en)
*
|
1998-06-16 |
1999-12-23 |
Merck Sharp & Dohme Limited |
Triazolo-pyridine derivatives as ligands for gaba receptors
|
|
JP2002527520A
(ja)
|
1998-10-21 |
2002-08-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物、その製造及び使用
|
|
US6627651B1
(en)
|
1999-05-07 |
2003-09-30 |
Takeda Chemical Industries, Ltd. |
Cyclic compounds and uses thereof
|
|
AU7072200A
(en)
|
1999-08-27 |
2001-03-26 |
Procter & Gamble Company, The |
Fast-acting formulation components, compositions and laundry methods employing same
|
|
CN100383230C
(zh)
|
1999-08-27 |
2008-04-23 |
宝洁公司 |
配制组分的可控制利用,使用该组分的组合物和洗衣方法
|
|
CZ2002720A3
(cs)
|
1999-08-27 |
2002-09-11 |
The Procter & Gamble Company |
Složky zesilující bělení, prostředky a způsoby praní s využitím složek zesilujících bělení
|
|
BR0013647A
(pt)
|
1999-08-27 |
2002-05-07 |
Procter & Gamble |
Métodos de lavagem com proteção á cor empregando componentes de formulação catiÈnicas
|
|
BR0013643A
(pt)
|
1999-08-27 |
2002-05-07 |
Procter & Gamble |
Métodos para lavar roupa seguros para as cores empregando componentes de formulações zwitteriÈnicos
|
|
WO2001016276A1
(en)
|
1999-08-27 |
2001-03-08 |
The Procter & Gamble Company |
Stability enhancing formulation components, compositions and laundry methods employing same
|
|
JP2003508585A
(ja)
|
1999-08-27 |
2003-03-04 |
ザ、プロクター、エンド、ギャンブル、カンパニー |
安定した処方成分、それらの成分を使用する組成物および洗濯方法
|
|
AU5652001A
(en)
|
2000-05-15 |
2001-11-26 |
Darwin Discovery Limited |
Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
|
|
RU2272030C2
(ru)
|
2000-08-01 |
2006-03-20 |
Оно Фармасьютикал Ко., Лтд. |
Производные 3,4-дигидроизохинолина и фармацевтический агент, включающий его в качестве активного ингредиента
|
|
AU2001288485A1
(en)
|
2000-08-29 |
2002-03-13 |
Balekudru Devadas |
Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
|
|
JP2002205992A
(ja)
|
2000-11-08 |
2002-07-23 |
Takeda Chem Ind Ltd |
二環式トリアゾロン誘導体およびそれを含有する除草剤
|
|
WO2002051441A1
(fr)
|
2000-12-26 |
2002-07-04 |
Sankyo Company, Limited |
Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
|
|
PL363959A1
(en)
|
2001-03-09 |
2004-11-29 |
Pfizer Products Inc. |
Triazolopyridines as anti-inflammatory agents
|
|
US6998408B2
(en)
|
2001-03-23 |
2006-02-14 |
Bristol-Myers Squibb Pharma Company |
6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
|
|
US20030114448A1
(en)
|
2001-05-31 |
2003-06-19 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
JP2005089298A
(ja)
|
2001-09-18 |
2005-04-07 |
Japan Tobacco Inc |
ナフタレン化合物及びその医薬用途
|
|
US7196108B2
(en)
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
|
JP2003277384A
(ja)
|
2002-03-26 |
2003-10-02 |
Kyorin Pharmaceut Co Ltd |
縮合ニ環式ピリジン誘導体
|
|
JP2003321461A
(ja)
|
2002-04-25 |
2003-11-11 |
Kyorin Pharmaceut Co Ltd |
縮合ビフェニル誘導体
|
|
EP1537090A1
(en)
|
2002-08-13 |
2005-06-08 |
Warner-Lambert Company Llc |
Chromone derivatives as matrix metalloproteinase inhibitors
|
|
US7005523B2
(en)
*
|
2002-08-30 |
2006-02-28 |
Pfizer Inc. |
Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
|
|
PA8579601A1
(es)
*
|
2002-08-30 |
2004-05-07 |
Pfizer Prod Inc |
Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
|
|
JPWO2004026292A1
(ja)
|
2002-09-20 |
2006-01-12 |
株式会社ツムラ |
鎮咳薬
|
|
US20040204404A1
(en)
|
2002-09-30 |
2004-10-14 |
Robert Zelle |
Human N-type calcium channel blockers
|
|
AU2003285946A1
(en)
|
2002-10-22 |
2004-05-13 |
The Trustees Of The University Of Pennsylvania |
Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases
|
|
BR0315796A
(pt)
|
2002-11-07 |
2005-09-13 |
Merck & Co Inc |
Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero
|
|
AU2004204814B2
(en)
|
2003-01-13 |
2009-10-08 |
Cortex Pharmaceuticals, Inc. |
Method of treating cognitive decline due to sleep deprivation and stress
|
|
MY142651A
(en)
|
2003-03-18 |
2010-12-15 |
Merck Sharp & Dohme |
Biaryl substituted triazoles as sodium channel blockers
|
|
DE10317526A1
(de)
|
2003-04-16 |
2004-11-04 |
Degussa Ag |
Verfahren zum Delignifizieren von ligninhaltigen Faserstoffen
|
|
CN100384856C
(zh)
|
2003-04-17 |
2008-04-30 |
麦克公司 |
趋化因子受体活性调节剂杂环基环戊基四氢异喹啉和杂环基环戊基四氢吡啶并吡啶
|
|
WO2004096767A1
(en)
*
|
2003-04-25 |
2004-11-11 |
H. Lundbeck A/S |
Sustituted indoline and indole derivatives
|
|
WO2005002520A2
(en)
*
|
2003-07-01 |
2005-01-13 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
NZ545717A
(en)
|
2003-08-05 |
2009-12-24 |
Vertex Pharma |
Hydrogenated quinazoline derivatives as inhibitors of voltage-gated ion channels
|
|
US20050239767A1
(en)
|
2003-10-28 |
2005-10-27 |
Chan Michael K |
Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands
|
|
EP1708709A1
(en)
|
2003-12-18 |
2006-10-11 |
Pfizer Products Incorporated |
METHODS OF TREATING ACUTE INFLAMMATION IN ANIMALS WITH p38 MAP KINASE INHIBITORS
|
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
GB0412986D0
(en)
|
2004-06-10 |
2004-07-14 |
Xention Discovery Ltd |
Compounds
|
|
WO2006002470A1
(en)
|
2004-06-30 |
2006-01-12 |
Monash University |
Chiral ligands for asymmetric catalysis
|
|
JP2006063064A
(ja)
|
2004-07-27 |
2006-03-09 |
Takeda Chem Ind Ltd |
受容体作動剤
|
|
JP2007297283A
(ja)
|
2004-07-28 |
2007-11-15 |
Santen Pharmaceut Co Ltd |
新規桂皮酸関連化合物
|
|
AU2005272627A1
(en)
|
2004-08-13 |
2006-02-23 |
Amgen Inc. |
Substituted benzofused heterocycles
|
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
|
ATE473742T1
(de)
|
2004-08-23 |
2010-07-15 |
Merck Sharp & Dohme |
Kondensierte triazolderivate als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
|
|
AU2005285083B2
(en)
|
2004-09-13 |
2011-03-10 |
Merck Sharp & Dohme Corp. |
Tricyclic anilide spirohydantoin CGRP receptor antagonists
|
|
WO2006048727A1
(en)
|
2004-11-02 |
2006-05-11 |
Pfizer Products Inc. |
Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor
|
|
US7579348B2
(en)
*
|
2005-02-25 |
2009-08-25 |
Pgxhealth, Llc |
Derivatives of 8-substituted xanthines
|
|
TW200643015A
(en)
|
2005-03-11 |
2006-12-16 |
Akzo Nobel Nv |
2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
|
|
AR056317A1
(es)
|
2005-04-20 |
2007-10-03 |
Xenon Pharmaceuticals Inc |
Compuestos de oxindol y composicion farmaceutica
|
|
PT1881823E
(pt)
|
2005-05-17 |
2015-03-02 |
Sarcode Bioscience Inc |
Composições e métodos para o tratamento de transtornos oculares
|
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
|
CN101243091A
(zh)
|
2005-06-17 |
2008-08-13 |
惠氏公司 |
用作5－羟色胺抑制剂和5－ht1a激动剂和拮抗剂的三环化合物
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
WO2007004028A2
(en)
|
2005-06-30 |
2007-01-11 |
Ranbaxy Laboratories Limited |
Processes for the preparation of penems and its intermediate
|
|
GB0516963D0
(en)
*
|
2005-08-18 |
2005-09-28 |
Carbonite Corp |
Liquid dispensers
|
|
WO2007023750A1
(ja)
|
2005-08-26 |
2007-03-01 |
National University Corporation University Of Toyama |
乾燥羊膜及び羊膜の乾燥処理方法
|
|
CA2621255A1
(en)
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
|
EP1940850A2
(en)
|
2005-09-23 |
2008-07-09 |
Schering Corporation |
Fused tetracyclic mglur1 antagonists as therapeutic agents
|
|
US20090022694A1
(en)
|
2005-10-18 |
2009-01-22 |
Distefano Peter |
Sirt1 inhibition
|
|
TW200804290A
(en)
|
2005-11-15 |
2008-01-16 |
Astrazeneca Ab |
Compounds and uses thereof
|
|
EP1954268B1
(en)
|
2005-11-18 |
2012-09-26 |
Merck Sharp & Dohme Corp. |
Spirolactam bicyclic cgrp receptor antagonists
|
|
AU2006316627A1
(en)
|
2005-11-18 |
2007-05-31 |
Merck Sharp & Dohme Corp. |
Spirolactam aryl CGRP receptor antagonists
|
|
TW200734342A
(en)
|
2005-12-15 |
2007-09-16 |
Astrazeneca Ab |
New compounds for the treatment of cardiac arrhythmias
|
|
KR20080082618A
(ko)
*
|
2005-12-16 |
2008-09-11 |
알콘, 인코퍼레이티드 |
Ａｌｋ5 조절제를 사용한 안압의 조절
|
|
US8013073B2
(en)
|
2005-12-30 |
2011-09-06 |
Chevron Oronite Company Llc |
Method for preparing polyolefins containing vinylidine end groups using nonaromatic heterocyclic compounds
|
|
BRPI0710110A2
(pt)
*
|
2006-03-31 |
2011-08-02 |
Novartis Ag |
compostos orgánicos
|
|
WO2007146284A2
(en)
*
|
2006-06-12 |
2007-12-21 |
Vertex Pharmaceuticals Incorporated |
Thienopyrimidines useful as modulators of ion channels
|
|
WO2008005338A1
(en)
|
2006-06-29 |
2008-01-10 |
Arena Pharmaceuticals, Inc. |
Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
|
|
WO2008005457A2
(en)
|
2006-06-30 |
2008-01-10 |
Sunesis Pharmaceuticals |
Pyridinonyl pdk1 inhibitors
|
|
WO2008007661A1
(fr)
|
2006-07-11 |
2008-01-17 |
Takeda Pharmaceutical Company Limited |
Composé hétérocyclique tricycique et son utilisation
|
|
CA2656855A1
(en)
*
|
2006-07-12 |
2008-01-17 |
Christoph Luthy |
Triazolopyridine derivatives as herbicides
|
|
PE20080403A1
(es)
*
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US7790741B2
(en)
*
|
2006-10-06 |
2010-09-07 |
Abbott Laboratories |
Imidazothiazoles and imidazoxazoles
|
|
WO2008118141A2
(en)
|
2006-10-17 |
2008-10-02 |
Acadia Pharmaceuticals Inc. |
Use of cannabinoid modulating compounds in combination with other therapeutic compounds for adjunctive therapy
|
|
ES2555803T3
(es)
|
2006-10-23 |
2016-01-08 |
Cephalon, Inc. |
Fusión de derivados bicíclicos 2,4-diaminopirimidina como utilizar inhibidores ALK y c-Met
|
|
CA2667826C
(en)
|
2006-10-28 |
2013-10-08 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
EP2128134A1
(en)
|
2006-11-02 |
2009-12-02 |
Shionogi&Co., Ltd. |
Sulfonylurea derivative capable of selectively inhibiting mmp-13
|
|
CA2670651A1
(en)
|
2006-12-21 |
2008-07-03 |
Cv Therapeutics, Inc. |
Reduction of cardiovascular symptoms
|
|
US8076350B2
(en)
|
2006-12-22 |
2011-12-13 |
Abbott Laboratories |
Spirocyclic azaadamantane derivatives and methods of use
|
|
AR065081A1
(es)
|
2007-01-29 |
2009-05-13 |
Xenon Pharmaceuticals Inc |
Compuestos de quinazolinona y pirimidona fusionados y composicion farmaceutica
|
|
JP2010520237A
(ja)
|
2007-02-28 |
2010-06-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ナトリウムチャネル遮断薬としての置換ベンゾジアゼピノン、ベンゾオキサアゼピノン及びベンゾチアゼピノン
|
|
US8247403B2
(en)
|
2007-03-07 |
2012-08-21 |
Takeda Pharmaceutical Company Limited |
Benzoxazepine derivatives and use thereof
|
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
|
WO2008134553A1
(en)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Methods of using bicyclic compounds in treating sodium channel-mediated diseases
|
|
WO2008144483A2
(en)
|
2007-05-18 |
2008-11-27 |
Armgo Pharma, Inc. |
Agents for treating disorders involving modulation of ryanodine receptors
|
|
WO2009005675A1
(en)
|
2007-06-28 |
2009-01-08 |
Abbott Laboratories |
Novel triazolopyridazines
|
|
WO2009026444A1
(en)
|
2007-08-22 |
2009-02-26 |
President And Fellows Of Harvard College |
Ryanodine channel binders and uses thereof
|
|
US20090069300A1
(en)
|
2007-09-12 |
2009-03-12 |
Wyeth |
Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
|
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
DK2231662T3
(da)
|
2007-12-19 |
2011-08-29 |
Genentech Inc |
8-Anilinoimidazopyridiner og deres anvendelse som anticancer- og/eller antiinflammatoriske midler
|
|
US20110112079A1
(en)
|
2008-01-09 |
2011-05-12 |
Thomas Craig J |
Phosphodiesterase inhibitors
|
|
EA201070914A1
(ru)
|
2008-02-06 |
2011-04-29 |
Гайлид Сайэнсиз, Инк. |
Применение ранолазина для лечения боли
|
|
WO2009137499A1
(en)
|
2008-05-05 |
2009-11-12 |
Envivo Pharmaceuticals, Inc. |
Inhibitors of histone deacetylase
|
|
WO2009137462A2
(en)
|
2008-05-05 |
2009-11-12 |
Envivo Pharmaceuticals, Inc. |
Methods for treating cognitive disorders using inhibitors of histone deacetylase
|
|
DE102008024182A1
(de)
|
2008-05-19 |
2009-11-26 |
Merck Patent Gmbh |
Verbindungen für organische elektronische Vorrichtung
|
|
CA2726508C
(en)
|
2008-06-17 |
2016-06-07 |
Astrazeneca Ab |
Pyridine compounds
|
|
EP2307027A4
(en)
|
2008-07-11 |
2012-08-15 |
Neumedics |
TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE PROPERTIES
|
|
EP2314583B1
(en)
|
2008-08-12 |
2015-02-25 |
Nippon Soda Co., Ltd. |
Nitrogenated heterocyclic derivative, and agricultural or horticultural bactericidal agent
|
|
EP2323974A1
(en)
|
2008-08-18 |
2011-05-25 |
Ube Industries, Ltd. |
Methods for preparing fluoroalkyl arylsulfinyl compounds and fluorinated compounds thereto
|
|
WO2010028173A2
(en)
|
2008-09-04 |
2010-03-11 |
Gilead Palo Alto, Inc. |
Method of treating atrial fibrillation
|
|
US20100113461A1
(en)
|
2008-10-29 |
2010-05-06 |
Gilead Palo Alto, Inc. |
Substituted heterocyclic compounds
|
|
WO2010056527A2
(en)
|
2008-10-30 |
2010-05-20 |
Gilead Palo Alto, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
|
MX2011006084A
(es)
|
2008-12-08 |
2011-09-06 |
Sirtris Pharmaceuticals Inc |
Isoindolinona y analogos relacionados como moduladores de sirtuina.
|
|
CN102292338B
(zh)
|
2008-12-08 |
2016-09-28 |
萌蒂制药国际有限公司 |
酪氨酸激酶蛋白受体拮抗剂
|
|
FR2943342B1
(fr)
|
2009-03-20 |
2011-03-04 |
Servier Lab |
Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
BRPI1012282A2
(pt)
|
2009-03-27 |
2015-09-22 |
Presidio Pharmaceuticals Inc |
inibidores de anel fundidos da hepatite c.
|
|
US20100305093A1
(en)
|
2009-04-09 |
2010-12-02 |
Exelixis, Inc. |
Inhibitors of mTOR and Methods of Making and Using
|
|
DK2464645T3
(en)
|
2009-07-27 |
2017-10-23 |
Gilead Sciences Inc |
CONDENSED, HETEROCYCLIC COMPOUNDS AS IRON CHANNEL MODULATORS
|
|
PL2483278T3
(pl)
|
2009-09-28 |
2014-05-30 |
Hoffmann La Roche |
Związki benzoksazepinowe stanowiące inhibitor pi3k i ich zastosowanie w leczeniu nowotworu
|
|
CN104530079B
(zh)
|
2009-12-18 |
2017-10-20 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
|
TWI508726B
(zh)
|
2009-12-21 |
2015-11-21 |
Gilead Sciences Inc |
治療心房纖維性顫動之方法
|
|
MX2012015096A
(es)
|
2010-07-02 |
2013-05-28 |
Gilead Sciences Inc |
Compuestos heterociclicos fusionados como moduladores del canal ion.
|
|
WO2012019076A1
(en)
|
2010-08-06 |
2012-02-09 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for preventing and treating cardiac ischemia/reperfusion injury
|
|
WO2012019071A1
(en)
|
2010-08-06 |
2012-02-09 |
The Trustees Of Columbia University In The City Of New York |
Methods of preventing and treating sarcopenia
|
|
WO2012037105A1
(en)
|
2010-09-14 |
2012-03-22 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating, ameliorating or preventing stress-induced neuronal disorders and diseases
|
|
US8999967B2
(en)
|
2010-09-29 |
2015-04-07 |
Presidio Pharmaceuticals, Inc. |
Tricyclic fused ring inhibitors of hepatitis C
|
|
US20140378436A9
(en)
|
2010-11-24 |
2014-12-25 |
Exelixis, Inc. |
Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their use and Manufacture
|
|
AU2012253653A1
(en)
|
2011-05-10 |
2013-05-02 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as sodium channel modulators
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
NO3175985T3
(me)
|
2011-07-01 |
2018-04-28 |
|
|
|
AU2013203252B2
(en)
|
2012-01-27 |
2015-08-20 |
Gilead Sciences, Inc. |
Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
|